Bristol Myers Squibb

Reports of preliminary merger talks between British pharmaceutical giant AstraZeneca and its American competitor Bristol Myers Squibb have sparked significant market interest this week. This is a move that could lead to one of the largest deals in the industry's history, creating a combined company worth approximately $400 billion. Although a senior source denied the existence of the talks and...